Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

L-carnitine, a friend or foe for cardiovascular disease? A Mendelian randomization study.

BMC medicine - 1 Sept 2022

Zhao Jie V, Burgess Stephen, Fan Bohan, Schooling C Mary

Abstract excerpt

BACKGROUND: L-carnitine is emerging as an item of interest for cardiovascular disease (CVD) prevention and treatment, but controversy exists. To examine the effectiveness and safety of L-carnitine, we assessed how genetically different levels of L-carnitine are associated with CVD risk and its risk factors. Given higher CVD incidence and L-carnitine in men, we also examined sex-specific associations. METHODS: We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Diseases
Share to Carnitine
Share to Coronary Artery Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diabetes Mellitus, Type 2

Share to Genome-Wide Association Study

Share to Mendelian Randomization Analysis

Share to Polymorphism, Single Nucleotide

Share to Risk Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 36045366
DOI: 10.1186/s12916-022-02477-z
PMCID: PMC9434903

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

L-carnitine, a friend or foe for cardiovascular disease? A Mendelian randomization study.PMID 36045366Read ↗

Vegetable intake and cardiovascular risk: genetic evidence from Mendelian randomizationSemantic proximity Read ↗

Effect of linoleic acid on ischemic heart disease and its risk factors: a Mendelian randomization studySemantic proximity Read ↗

Telomere length and the risk of cardiovascular diseases: A Mendelian randomization studySemantic proximity Read ↗

A stratified study of human blood metabolites and coronary artery diseases-A Mendelian randomization study.Semantic proximity Read ↗

Efficacy and safety of low levels of low-density lipoprotein cholesterol: trans-ancestry linear and non-linear Mendelian randomization analysesSemantic proximity Read ↗

Assessing dose-response relations of lipid traits with coronary artery disease, all-cause mortality, and cause-specific mortality: a linear and non-linear Mendelian randomization studySemantic proximity Read ↗

Causality of Genetically Determined Monounsaturated Fatty Acids on Risk of Cardiovascular Disease: A Mendelian Randomization StudySemantic proximity Read ↗

Mendelian Randomization Indicates Enhanced Lipid Control is Essential for Omega-3’s Cardiovascular ProtectionSemantic proximity Read ↗

Causal relationships of circulating amino acids with cardiovascular disease: a trans-ancestry Mendelian randomization analysis.Semantic proximity Read ↗

Evaluating the causal relationship of Levo-carnitine and risk of schizophrenia: a bidirectional two-sample mendelian randomization study.Semantic proximity Read ↗

Alcohol Consumption and Cardiovascular Disease: A Mendelian Randomization Study.Semantic proximity Read ↗

No causal effects of plasma homocysteine levels on the risk of coronary heart disease or acute myocardial infarction: A Mendelian randomization study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.